视网膜中央静脉阻塞手术治疗何去何从?  

Where will the surgical treatment of central retinal vein occlusion go?

作　　者：魏文斌[1] 

机构地区：[1]首都医科大学附属北京同仁医院北京同仁眼科中心北京市眼科学与视觉科学重点实验室,100730

出　　处：《眼科》2009年第4期217-220,共4页Ophthalmology in China

摘　　要：近年来对于视网膜中央静脉阻塞(CRVO)手术疗法如放射状视神经切开术、玻璃体切割术联合或不联合内界膜剥除、视网膜静脉置管直接注射组织纤溶酶原激活剂、眼动脉溶栓疗法等研究报告较多。但多数疗法的临床效果争议颇多、作用机制尚未明确,并发症也不容忽视。在临床常规应用之前,对其亟需开展多中心大样本的前瞻性随机对照研究。There are many research reports about surgical treatments for central retinal vein occlusion （CRVO） up to date, such as radial optic neurotomy, vitrectomy combined with internal limiting membrane removal or not, t-PA retinal venous thrombolysis, ophthalmic artery thrombolysis and so on, However, the most of the therapeutic methods are controversial, the action mechanism of some therapies are still not clear, and their complications should be taken attendtion seriously. So in the future it is necessary to conduct muhiple centre prospective randomized controlled trials for evaluating the role of different surgical therapies for CRVO. （Ophthalmol CHN, 2009, 18： 217-220）

关 键 词：视网膜中央静脉阻塞 外科学 放射状视神经切开术 述评 

分 类 号：R779.6[医药卫生—眼科]